 Bone Neoplasms
"Bone Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer located in bone tissue or specific BONES.
| Descriptor ID |
D001859
|
| MeSH Number(s) |
C04.588.149 C05.116.231
|
| Concept/Terms |
Bone Neoplasms- Bone Neoplasms
- Bone Neoplasm
- Neoplasm, Bone
- Neoplasms, Bone
|
Below are MeSH descriptors whose meaning is more general than "Bone Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Bone Neoplasms".
This graph shows the total number of publications written about "Bone Neoplasms" by people in this website by year, and whether "Bone Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 1999 | 1 | 2 | 3 | | 2001 | 1 | 1 | 2 | | 2002 | 2 | 0 | 2 | | 2003 | 4 | 0 | 4 | | 2004 | 3 | 0 | 3 | | 2005 | 2 | 0 | 2 | | 2006 | 5 | 2 | 7 | | 2007 | 2 | 1 | 3 | | 2008 | 3 | 0 | 3 | | 2009 | 5 | 2 | 7 | | 2010 | 6 | 1 | 7 | | 2011 | 5 | 2 | 7 | | 2012 | 9 | 2 | 11 | | 2013 | 6 | 0 | 6 | | 2014 | 5 | 2 | 7 | | 2015 | 12 | 3 | 15 | | 2016 | 6 | 0 | 6 | | 2017 | 10 | 3 | 13 | | 2018 | 4 | 1 | 5 | | 2019 | 4 | 1 | 5 | | 2020 | 2 | 2 | 4 | | 2021 | 5 | 0 | 5 | | 2022 | 8 | 0 | 8 | | 2023 | 5 | 0 | 5 | | 2024 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Bone Neoplasms" by people in Profiles.
-
Ihle CL, Straign DM, Canari JA, Torkko KC, Zolman KL, Smith EE, Owens P. Unique macrophage phenotypes activated by BMP signaling in breast cancer bone metastases. JCI Insight. 2024 Jan 09; 9(1).
-
Wills A, Dibbern M, Frierson HF, Raghavan SS. Metastatic Undifferentiated Melanoma Mimicking a Primary Bone Tumor: A Potential Diagnostic Pitfall. Am J Dermatopathol. 2024 Mar 01; 46(3):170-172.
-
Black JO, Al-Ibraheemi A, Arnold MA, Coffin CM, Davis JL, Parham DM, Rudzinski ER, Shenoy A, Surrey LF, Tan SY, Spunt SL. The Pathologic Diagnosis of Pediatric Soft Tissue Tumors in the Era of Molecular Medicine: The Sarcoma Pediatric Pathology Research Interest Group Perspective. Arch Pathol Lab Med. 2024 Jan 01; 148(1):107-116.
-
Santoni M, Massari F, Takeshita H, Tapia JC, Dionese M, Pichler R, Rizzo M, Lam ET, Grande E, Kemp R, Molina-Cerrillo J, Calabr? F, Tural D, K?ronya Z, Kucharz J, Fiala O, Seront E, Kopp RM, Abahssain H, Kopecky J, Martignetti A, Kanesvaran R, Zakopoulou R, Ansari J, Landmesser J, Mollica V, Porta C, Bellmunt J, Salah S, Santini D. Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study. Clin Exp Med. 2023 Dec; 23(8):5413-5422.
-
Schutz JF, Iorio ML, Marshall CB, Clay MR, Gimarc DC, Park A. Adamantinoma of the Ulnar Shaft Reconstructed With a Vascularized Free Fibula. Orthopedics. 2024 Mar-Apr; 47(2):e102-e105.
-
Subbiah V, Chawla SP, Conley AP, Wilky BA, Tolcher A, Lakhani NJ, Berz D, Andrianov V, Crago W, Holcomb M, Hussain A, Veldstra C, Kalabus J, O'Neill B, Senne L, Rowell E, Heidt AB, Willis KM, Eckelman BP. Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma. Clin Cancer Res. 2023 08 15; 29(16):2988-3003.
-
Weiser DA, Hayashi M, Applebaum MA. Breaking Up Isn't Hard to Do: Isolating Cell-free DNA Fragments in Osteosarcoma. Clin Cancer Res. 2023 06 01; 29(11):2017-2019.
-
Marinoff AE, Spurr LF, Fong C, Li YY, Forrest SJ, Ward A, Doan D, Corson L, Mauguen A, Pinto N, Maese L, Colace S, Macy ME, Kim A, Sabnis AJ, Applebaum MA, Laetsch TW, Glade-Bender J, Weiser DA, Anderson M, Crompton BD, Meyers P, Zehir A, MacConaill L, Lindeman N, Nowak JA, Ladanyi M, Church AJ, Cherniack AD, Shukla N, Janeway KA. Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma. JCO Precis Oncol. 2023 03; 7:e2200334.
-
Mohseni Garakani M, Cooke ME, Weber MH, Wertheimer MR, Ajji A, Rosenzweig DH. A 3D, Compartmental Tumor-Stromal Microenvironment Model of Patient-Derived Bone Metastasis. Int J Mol Sci. 2022 Dec 21; 24(1).
-
Ihle CL, Wright-Hobart SJ, Owens P. Therapeutics targeting the metastatic breast cancer bone microenvironment. Pharmacol Ther. 2022 11; 239:108280.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|